Richard Mularski to Interferon beta-1a
This is a "connection" page, showing publications Richard Mularski has written about Interferon beta-1a.
Connection Strength
0.201
-
Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial. Lancet Respir Med. 2021 12; 9(12):1365-1376.
Score: 0.201